Clay B. Siegall
2019
Compensation breakdown
| Non-Equity Incentive Plan | $1,903,500 |
|---|---|
| Option Awards | $3,502,217 |
| Salary | $963,369 |
| Stock Awards | $8,137,179 |
| Other | $15,230 |
| Total | $14,521,495 |
Siegall received $8.1M in stock awards, accounting for 56% of the total pay in 2019.
Siegall also received $1.9M in non-equity incentive plan, $3.5M in option awards, $963.4K in salary and $15.2K in other compensation.
Rankings
In 2019, Clay B. Siegall's compensation ranked 357th out of 13,971 executives tracked by ExecPay. In other words, Siegall earned more than 97.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 357 out of 13,971 | 97th |
Division Manufacturing | 126 out of 5,701 | 98th |
Major group Chemicals And Allied Products | 38 out of 2,200 | 98th |
Industry group Drugs | 30 out of 1,886 | 98th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 389 | 99th |
Pay ratio
| Clay B. Siegall's Pay | $14,521,495 |
|---|---|
| Median Employee's Pay | $222,352 |
| Pay Ratio | 65to 1 |
In 2019, the annual total compensation of Clay B. Siegall was $14,521,495.
The annual total compensation of the median employee at Seattle Genetics was $222,352.
The ratio of Clay B. Siegall's pay to the pay of median employee was therefore 65 to one.
Siegall's colleagues
We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2019.
2019
Roger Dansey
Seattle Genetics
Chief Medical Officer
2019
Robin Taylor
Seattle Genetics
Former Chief Commercial Officer
2019
Todd Simpson
Seattle Genetics
Chief Financial Officer
2019
Jean Liu
Seattle Genetics
General Counsel
2019
Chip Romp
Seattle Genetics